Influence of VEGFR2 gene polymorphism on the clinical outcomes of apatinib for patients with chemotherapy–refractory extensive-stage SCLC: a real-world retrospective study
Author:
Funder
the Key Program of Medical Science Research of Hebei Province
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Link
http://link.springer.com/content/pdf/10.1007/s10147-020-01849-w.pdf
Reference46 articles.
1. Saltos A, Antonia S (2020) Breaking the impasse: advances in treatment of small cell lung cancer. Clin Chest Med 41:269–280
2. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
3. Yu L, Lai Q, Gou L et al (2020) Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer. J Drug Target 1–11. https://doi.org/10.1080/1061186x.2020.1797050
4. Jones GS, Elimian K, Baldwin DR et al (2020) A systematic review of survival following anti-cancer treatment for small cell lung cancer. Lung Cancer 141:44–55
5. Dómine M, Moran T, Isla D et al (2020) SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019). Clin Transl Oncol 22:245–255
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Implication of PD‑L1 polymorphisms rs2297136 on clinical outcomes of patients with advanced NSCLC who received PD‑1 blockades: A retrospective exploratory study;Oncology Letters;2024-02-07
2. Association of VEGFR2 Gene Polymorphisms with Clinical Outcomes of Anti-Angiogenesis Therapy in Cancer Patients: A Systematic Review and Meta-Analysis;2024
3. Implication of KDR Polymorphism rs2071559 on Therapeutic Outcomes and Safety of Postoperative Patients with Gastric Cancer Who Received S-1-Based Adjuvant Chemotherapy: A Real-World Exploratory Study;Pharmacogenomics and Personalized Medicine;2023-11
4. The Association between Prognosis and Oral Mycobiota in Lung Cancer Patients Receiving Chemo-Immune Therapy;J BIOL REG HOMEOS AG;2023
5. Effectiveness and Safety of Anlotinib Monotherapy for Patients with Extensive-stage Small-Cell Lung Cancer Who Progressed to Chemotherapy: A Real-world Exploratory Study;Clinical Medicine Insights: Oncology;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3